APP and tauopathy: Indeed, AD is classified as a secondary tauopathy, as the mutations characterizing AD mainly affect the presenilin genes (PSEN1 and PSEN2) and the amyloid precursor protein gene (APP), resulting in an altered amyloid metabolism [76].